Solutions to Streamline Inventory Management
Drug Topics
APRIL 12, 2023
Autofill programs and metrics reporting can help pharmacists streamline their inventory management.
Wed.Apr 12, 2023
469 
FDA should remain the authority on the safety and effectiveness of medicines
PhRMA
APRIL 12, 2023
Recent district court rulings set an alarming precedent that calls into question the authority of the U.S. Food and Drug Administration (FDA) to determine the safety and effectiveness of new medicines.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Does Tirzepatide's Benefits in Patients with Type 2 Diabetes Make The Price Worth It?
Drug Topics
APRIL 12, 2023
Tirzepatide was associated with a greater reduction in hemoglobin A1c and body weight when compared to semaglutide. But with a current list price of $1,023 for a one-month supply, is tirzepatide (Mounjaro; Lilly) worth it?
New global analysis shows patient access challenges around the world
PhRMA
APRIL 12, 2023
Today PhRMA released a new report that analyzes the share of new medicines that are available in over 70 countries and how long patients wait to receive them. The Global Access to New Medicines Report includes comprehensive comparisons across countries in the G20, Organization for Economic Co-operation and Development (OECD) and several geographic regions.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Menopause May Increase Risk of Glaucoma but Estrogen Therapy Could Help, Study Finds
Drug Topics
APRIL 12, 2023
A recent study showed a link between menopause and increased glaucoma risk, with estrogen-based treatment being a possible solution.
What’s pharma doing wrong to improve trial diversity? ‘Everything’
PharmaVoice
APRIL 12, 2023
Pharma’s missing the mark when it comes to recruiting Black patients, and Ricki Fairley, CEO of The Black Breast Cancer Alliance, reveals what’s needed.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Study: Pandemic Shows Link to Increased Exposure of Opioids to Postpartum Women
Pharmacy Times
APRIL 12, 2023
Analysis indicates that there was a larger increase of filled prescriptions for individuals who delivered by cesarean birth.
Opinion: Harvey Washington Wiley campaigned for food and drug safety in the early 20th century. Digital mental health needs its own Wiley moment
STAT
APRIL 12, 2023
Prior to the early 20th century, America had no regulation of medications or food additives. Formaldehyde was used to preserve meat, morphine was included in infant “soothing syrups,” and marketing, not science, drove the promotion of tonics and medications. The 1906 Food and Drug Act was the first in a series of consumer protection laws focused on setting standards for safe and effective medications and food additives.
12 Skills Pharmacy Students Can Apply to Become Leaders in Their Practice
Pharmacy Times
APRIL 12, 2023
Pharmacists serve as advocates to optimize patient pharmaceutical care, advance the profession, and positively influence the community.
Woman of the Week: uMotif’s Julia Lakeland
PharmaVoice
APRIL 12, 2023
The chief product officer’s work in transforming clinical trial technology is driven by people.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Updates on 503A Compounding: The Impact of Drug Shortages
Pharmacy Times
APRIL 12, 2023
The FDA’s temporary Guidance for 503A compounding of shortage drugs was meant to be temporary and withdrawn once COVID-19 ended.
3 Digital Health Strategies to Improve Health Plan Member Experience
Fierce Healthcare
APRIL 12, 2023
3 Digital Health Strategies to Improve Health Plan Member Experience mteefey Wed, 04/12/2023 - 14:16
Study: Individuals With HIV Have Higher Risk of Depression, Suicide
Pharmacy Times
APRIL 12, 2023
The risk is particularly high in the first 2 years after an HIV diagnosis.
CDC seeks new weapons against antimicrobial resistance
Fierce Healthcare
APRIL 12, 2023
CDC seeks new weapons against antimicrobial resistance fdiamond Wed, 04/12/2023 - 16:29
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
There Are Two Significant Advantages to the Decriminalization of Psychedelics
Pharmacy Times
APRIL 12, 2023
To build a brighter, healthier, and more equitable future for all US citizens, there is an indisputable need to decriminalize psychedelic medicines.
A majority of payers used outcomes-based contracting last year: survey
Fierce Healthcare
APRIL 12, 2023
A majority of payers used outcomes-based contracting last year: survey pminemyer Wed, 04/12/2023 - 13:04
Study: Participation in Clinical Trials Associated With Improved Overall Survival in Patients with Ovarian Cancer
Pharmacy Times
APRIL 12, 2023
Availability of clinical trials in the gynecologic cancer care space are increasing, but it is important to be mindful of current racial disparities.
Microsoft expands cloud capabilities for payers, rolls out new AI services
Fierce Healthcare
APRIL 12, 2023
Microsoft expands cloud capabilities for payers, rolls out new AI services hlandi Wed, 04/12/2023 - 11:42
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FDA Approves Expanded Indication for Hyqvia to Treat Pediatric Primary Immunodeficiency
Pharmacy Times
APRIL 12, 2023
During the 12-month trial period, Hyqvia was shown to be efficacious treating the occurrence of acute serious bacterial infections in children aged 2 through 16 years with primary immunodeficiency.
Taking healing into your own hands
Drug Store News
APRIL 12, 2023
The origin story of Element Apothec is like many other entrepreneurial endeavors, a product was developed and created because items available on the market didn’t meet the need.
Help Patients Improve Glycemic Control for T2D
Pharmacy Times
APRIL 12, 2023
Keeping blood glucose levels within a target range delays, prevents serious health complications associated with type 2 diabetes.
Opinion: Michael J. Fox: As a Parkinson’s patient, I felt a little left behind by biology’s century — until now
STAT
APRIL 12, 2023
Last fall in STAT, Matt Herper questioned whether the biomedical research enterprise is really laying the necessary groundwork to gain the full benefit of innovation in “biology’s century.” “The biggest looming problem is that… new technologies in biology [could] outpace our ability to assess them,” he observed.
Hard Stops for EMRs Reduces Rates of Hospital-Acquired Clostridioides difficile Infection
Pharmacy Times
APRIL 12, 2023
These are used to help reduce inappropriate testing, where an expert consults with medical directors of infection prevention and control for a test-order override.
Pre-merger Advocate Aurora Health logs $751M net loss across 2022
Fierce Healthcare
APRIL 12, 2023
Pre-merger Advocate Aurora Health logs $751M net loss across 2022 dmuoio Wed, 04/12/2023 - 12:38
A controversial hire at Arnold Ventures raises questions about the donor’s stance on addiction
STAT
APRIL 12, 2023
A philanthropic giant’s recent hire of a researcher with controversial theories on naloxone access is raising alarms among public health advocates who worry the move marks a shift in major donors’ approach to addiction treatment. Arnold Ventures, one of the largest nonprofit funders of criminal justice reform projects and a major player in drug policy circles, announced last month that Texas A&M University economist Jennifer Doleac would take over its criminal justice portfolio
HRG’s five notable products from March 2023
Drug Store News
APRIL 12, 2023
HRG reviewed 22 products in the health category, 169 in the wellness sector and 91 items in the beauty aisle to see which ones stood out as Products to Watch.
A Parkinson’s ‘game changer,’ backed by Michael J. Fox, could lead to new diagnostics and, someday, treatments
STAT
APRIL 12, 2023
NEW YORK — Michael J. Fox was sitting in his Upper East Side office surrounded by Emmys and an Oscar — one he received not for his acting but for his Parkinson’s philanthropy. (“Humanitarian stuff,” he said nonchalantly.) He wore blue trousers and a T-shirt, and Adidas sneakers with no socks. His hair, years ago always perfect, was a bit disheveled, and he was in constant movement in his chair, a hallmark of the Parkinson’s disease that has defined
Biogen to develop amyloid beta-targeting antibody platform
European Pharmaceutical Review
APRIL 12, 2023
Biogen has exercised the option to license Denali’s Antibody Transport Vehicle (ATV): Amyloid beta program (ATV:Aβ). [the aim of the collaboration is] to advance the next generation of Aβ immunotherapies for the treatment of Alzheimer’s disease” “This decision is an important next step of our collaboration with Denali… that aims to advance the next generation of Aβ immunotherapies for the treatment of Alzheimer’s disease,” stated Dominic Walsh, Head of the Neurodegenerative Research Unit a
LyGenesis and Imagine Pharma partner for type 1 diabetes therapies development
Pharmaceutical Technology
APRIL 12, 2023
Clinical-stage biotechnology firm LyGenesis has formed a joint research collaboration with Imagine Pharma to develop new cell therapies for type 1 diabetes (T1D). The companies will develop new cell therapies for patients with T1D, using LyGenesis’ allogeneic cell therapy platform and Imagine Pharma’s Type 1 Diabetes Activated Islet Progenitor Cells (T1D AIPCs).
Wireless pacemakers may work for children with slow heart rhythms — but first, doctors need child-sized catheters
STAT
APRIL 12, 2023
Pacemakers, relied upon by many patients with irregular heart rhythms, are not built for children. Scrambling up trees, hanging from monkey bars, and even the simple act of growing make the device more likely to fail. Roughly 1 in 15,000 children are born with congenital heart block , which causes an abnormally slow heart rate. The condition leads to lightheadedness, shortness of breath, and in serious cases, heart failure.
Eagle reaches settlement agreement with Dr. Reddy’s on Bendeka
Drug Store News
APRIL 12, 2023
Under the agreement, Dr. Reddy’s has the right to market its product beginning Nov. 17, 2027, or earlier based on certain circumstances.
Personalised blood pressure treatment shows efficacy
European Pharmaceutical Review
APRIL 12, 2023
Patients treated with blood pressure-lowering drugs can experience greater improvements from changing medication compared to doubling the dose of their current medication, a study from Sweden has shown. Researchers aimed to investigate whether there is an optimal blood pressure drug for each individual, and therefore a potential for personalised blood pressure treatment.
Walgreens, VillageMD expand to Colorado
Drug Store News
APRIL 12, 2023
The development includes three new primary care practices, two in Fort Collins and a third in Longmont.
Let's personalize your content